Figure.3. (IMAGE)

Osaka University

Figure.3.

Caption

Anti-tumor effect of ivermectin and its combination therapy : Ivermectin, FDA approved anti-parasitic drug, showed KPNB1-dependent anti-tumor effect (A) and synergistically suppressed xenograft tumor growth in combination with paclitaxel, a first-line anticancer drug for epithelial ovarian cancer (B).

Credit

Osaka University

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.